press releases rule

Archives: Search / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008

Sep 16, 2014
-- Mark Pimentel, M.D., of Cedars-Sinai Delivered Keynote Presentation on Mechanism of Action --
Sep 12, 2014
-- Company Expects to File IND to Support Clinical Trials in Mid-2015 --
Sep 11, 2014
-- Conference Call Scheduled for Friday, September 12, 2014, at 9:15 a.m. EDT --
Sep 10, 2014
-- Keynote Speaker: Mark Pimentel, M.D., FRCP(C), Director, GI Motility Program and Laboratory, Cedars-Sinai Medical Center; Chairman, Synthetic Biologics' C-IBS Clinical Advisory Board --
Sep 8, 2014
-- SYN-005 Neutralizing Antibody Combination Protects Against Pertussis in Murine and Non-Human Primate Models --
 

Print Email RSS